First CRISPR Clinical Trial Backed By US Companies Launches
Aug 31, 2018, 13:25 PM
by
Michael Croft
STAT | The first clinical trial of CRISPR-Cas9, co-sponsored by Vertex Pharmaceuticals, will test the genome-editing technique in patients with the blood disorder beta thalassemia.
August 31, 2018 | The first clinical trial of CRISPR-Cas9, co-sponsored by Vertex Pharmaceuticals, will test the genome-editing technique in patients with the blood disorder beta thalassemia. STAT